NEWARK, CA / ACCESS Newswire / June 1, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today ...
NEWARK, CA / ACCESS Newswire / May 28, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") ...
NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. (“Protagonist” or the “Company”) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, ...
Learn more Celebrations may be in order for Protagonist Therapeutics, Inc. (NASDAQ:PTGX) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results